Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
Ra Pharmaceuticals, Inc. (RARX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/25/2019 |
GN
| Rigrodsky & Long, P.A. Files Class Action Suit Against Ra Pharmaceuticals, Inc. |
| 11/23/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – RARX, IPHS, CISN, LPT |
| 11/16/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – WLH, CISN, RARX, TECD |
| 11/15/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, RARX, and IPHS Shareholders About Its Ongoing Investigations |
| 11/11/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – IPHS, INXN, RARX, VSI |
| 11/04/2019 |
GN
| Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – VSI, RARX, SRCI, UCFC |
| 11/04/2019 |
GN
| MERGER ALERT – RARX, EMPK, and CETV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies |
| 11/01/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, and RARX Shareholders About Its Ongoing Investigations |
| 10/29/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations |
| 10/24/2019 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 10/10/2019 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Ra Pharmaceuticals, Inc. to UCB S.A. is Fair to Shareholders |
| 10/10/2019 |
GN
| Ra Pharmaceuticals Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Ra Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – RARX |
| 08/15/2018 |
GN
| Report: Developing Opportunities within RA PHARMCTL INC, Oclaro, Emergent Biosolutions, Kennametal, Instructure, and Donegal Group — Future Expectations, Projections Moving into 2018 |
| 04/02/2018 |
GN
| Recent Analysis Shows Jack Henry & Associates, Omnicell, Surgery Partners, Floor & Decor, NVE, and RA PHARMCTL INC Market Influences — Renewed Outlook, Key Drivers of Growth |
| 01/30/2018 |
GN
| New Research: Key Drivers of Growth for VAREX IMAGING, DCP Midstream Partners, LP, Werner Enterprises, K12, RA PHARMCTL INC, and TOCAGEN INC — Factors of Influence, Major Initiatives and Sustained Production |
|
|